Cargando…
NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma
Ewing sarcoma (ES) is a cancer that may originate from stem mesenchymal or neural crest cells and is highly prevalent in children and adolescents. In recent years, targeted therapies against immune-related genes have shown good efficacy in a variety of cancers. However, effective targets for immunot...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662625/ https://www.ncbi.nlm.nih.gov/pubmed/34899858 http://dx.doi.org/10.3389/fgene.2021.771253 |